From research to approved treatment: overcoming the obstacles. (Record no. 3181472)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 00735 a2200229 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250512040731.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 198811s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0037-1963 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Wittes, R E |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19881122 |
245 00 - TITLE STATEMENT | |
Title | From research to approved treatment: overcoming the obstacles. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Seminars in hematology |
Date of publication, distribution, etc. | Jul 1988 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 38-42 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Research |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United States |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United States Food and Drug Administration |
773 0# - HOST ITEM ENTRY | |
Title | Seminars in hematology |
Related parts | vol. 25 |
-- | no. 3 Suppl 3 |
-- | p. 38-42 |
No items available.